FTI
71
-2
CSX
55
-2
CHRW
36
-3
TXT
65
-4
CHK
43
-7
PWR
68
-2
NFLX
65
-3
FRT
41
-4
IP
44
-3
INTU
61
-2
FAST
46
-4
MA
55
-2
JCI
46
-13
SPG
48
-2
LRCX
56
-2
ADBE
44
-2
ECL
70
-4
ACN
31
-2
BIIB
28
8
CMI
60
-2
FTI
71
-2
CSX
55
-2
CHRW
36
-3
TXT
65
-4
CHK
43
-7
PWR
68
-2
NFLX
65
-3
FRT
41
-4
IP
44
-3
INTU
61
-2
FAST
46
-4
MA
55
-2
JCI
46
-13
SPG
48
-2
LRCX
56
-2
ADBE
44
-2
ECL
70
-4
ACN
31
-2
BIIB
28
8
CMI
60
-2
Financhill
Back

scPharmaceuticals 10K Form

Sell
35

SCPH
scPharmaceuticals

Last Price:
4.71
Seasonality Move:
-9.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-13 10Q SCPH/scPharmaceuticals Quarterly
2020-05-12 10Q SCPH/scPharmaceuticals Quarterly
2020-03-24 10K SCPH/scPharmaceuticals Annual
2019-11-12 10Q SCPH/scPharmaceuticals Quarterly
2019-08-07 10Q SCPH/scPharmaceuticals Quarterly
2019-05-08 10Q SCPH/scPharmaceuticals Quarterly

Receive SCPH News And Ratings

See the #1 stock for the next 7 days that we like better than SCPH

SCPH Financial Statistics

Sales & Book Value

Annual Sales: $13.59M
Cash Flow: $-15.2M
Price / Cash Flow: 0
Annual Sales: $1.03
Price / Book: 4.72

Profitability

EPS (TTM): -1.42000
Net Income (TTM): $-54.81M
Gross Margin: $9.78M
Return on Equity: -91.95%
Return on Assets: -49.59%

scPharmaceuticals Earnings Forecast

Key scPharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 2 years for SCPH is 71.96%.
  • The Selling, General & Administrative Expenses for SCPH have been equal to 392.62% of Gross Profit Margin.
  • The Research & Development expenses have been 86.88% of Revenue.
  • The Interest Expense is -14.82% of Operating Income.
  • The Net Earning history of SCPH is -403.22% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

scPharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: SCPH
CUSIP: 810648
Website: scpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 1.04
Current Ratio: 7.08
Quick Ratio: 6.13

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SCPH Technical Analysis vs Fundamental Analysis

Sell
35
scPharmaceuticals (SCPH) is a Sell

Is scPharmaceuticals a Buy or a Sell?

  • scPharmaceuticals stock is rated a Sell
    The current scPharmaceuticals [SCPH] share price is $4.87. The Score for SCPH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.